New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 28, 2012
11:02 EDTPRGOPerrigo mentioned cautiously at JPMorgan
JP Morgan said shares of Perrigo are moving higher on speculation regarding the impact from the FDA panel increasing OTC drugs. The firm said this will not be a big positive as the pharmacist will still dispense the drug in a restricted access market, and it might not even be the store brand.
News For PRGO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 17, 2014
13:32 EDTPRGOPerrigo jumps after analyst discusses potential takeover by Teva
Subscribe for More Information
09:26 EDTPRGOPerrigo would be good acquisition for Teva, says RBC Capital
RBC Capital views Perrigo (PRGO) as an attractive acquisition target and says in a note to investors that it thinks a takeover could be a good strategic fit with solid accretion for Teva (TEVA). Teva has interest in over-the-counter products and its growth rate would be boosted by the merger, RBC believes. The firm assumes a $200 per share value for Perrigo in its acquisition assumptions. Shares of the over-the-counter and generic pharmaceuticals company closed yesterday at $153.77.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use